Doctoral Thesis
Refine
Document Type
- Doctoral Thesis (2) (remove)
Language
- English (2)
Has Fulltext
- yes (2)
Is part of the Bibliography
- no (2)
Keywords
- Zebrabärbling (2) (remove)
Institute
80% of chronic kidney diseases are caused by the loss and the damage of a differentiated and postmitotic cell type, the podocytes. The size-selectivity of the blood filtration barrier is highly dependent on the complex interdigitation of the podocyte foot processes as well as of the slit membrane which is spanned in between. Changes of this specific morphology as well as a detachment of podocytes lead to the clinical hallmark of a nephrotic syndrome e.g. proteinuria and oedema formation.
Since specific drugs or therapies are usually not available, patients are often dependent on dialysis and transplantation. Therefore, intensive studies are necessary to understand the pathogenesis of glomerulopathies as well as to identify specific drugs. In the past, it was already demonstrated that the zebrafish is an ideal model to study kidney function and to screen for drugs, since the larvae quickly develop a simple glomerulus that is comparable to the glomeruli of mice, rat and human.
In the present work, a zebrafish model was established to study a specific glomerulopathy named focal segmental glomerulosclerosis (FSGS). FSGS is mainly characterized by histology of the glomeruli which shows segmental scar formation and matrix deposition due to an activation of parietal epithelial cells (PEC) lining the Bowman’s capsule. For this purpose, we used the nitroreductase/metronidazole (NTR/MTZ) system, in which a cytotoxic agent is exclusively generated in podocytes by the enzyme NTR resulting in apoptosis of cells. Firstly, the parameters for development of an FSGS-like disease were evaluated and the glomerular response to podocyte depletion was examined during three days after the induction of podocyte damage. Using classic histological techniques, immunofluorescence staining and transmission electron microscopy, it was possible to demonstrate that zebrafish larvae phenocopy human FSGS in important characteristics after partial podocyte depletion. Secondly, by intravascular injection of fluorescence-labeled high molecular weight dextran, we found that the filtration barrier became leaky. Moreover, we identified a severe podocyte foot process effacement, formation of subpodocyte space pseudocysts and loss of the slit membrane protein podocin. Morphometrical, histological and ultrastructural analysis revealed an enlargement of the glomerulus, proliferation of cuboidal PECs and intraglomerular deposition of extracellular matrix components, all typical hallmarks of FSGS. Further, we observed adhesions between the parietal and the visceral glomerular cell layer forming sclerotic lesions. However, it remains still unclear whether an inflammatory response is involved in the development of sclerotic lesions. Our microscopic analysis provided some evidence for immigration of immunocompetent cells like neutrophils, presumably due to induction of apoptosis in our model.
Taken together, in the present work a zebrafish model was established with characteristics of mammals FSGS which will be useful for pathomechanism studies as well as for drug screening.
Podocytes are highly specialized kidney cells that are attached to the outer aspect of the glomerular capillaries and are damaged in more than 75% of patients with an impaired renal function. This specific cell type is characterized by a complex 3D morphology which is essential for proper filtration of the blood. Any changes of this unique morphology are directly associated with a deterioration of the size-selectivity of the filtration barrier. Since podocytes are postmitotic, there is no regenerative potential and the loss of these cells is permanent. Therefore, identification of small molecules that are able to protect podocytes is highly important. The aim of this work was to establish an in vivo high-content drug screening in zebrafish larvae. At first, we looked for a reliable podocyte injury model which is fast, reproducible and easy to induce. Since adriamycin is commonly used in rodents to damage podocytes, we administered it to the larvae and analyzed the phenotype by in vivo microscopy, (immuno-) histology and RT-(q)PCR. However, adriamycin did not result in a podocyte-specific injury in zebrafish larvae. Subsequently, we decided to use a genetic ablation model which specifically damages podocytes in zebrafish larvae. Treatment of transgenic zebrafish larvae with 80 µM metronidazole for 48 hours generated an injury resembling focal and segmental glomerulosclerosis which is characterized by podocyte foot process effacement, cell depletion and proteinuria. Following this, we established an in vivo high-content screening system by the use of a specific screening zebrafish strain. This screening strain expresses a circulating 78 kDa eGFP-labeled Vitamin D-binding fusion protein, which passes the filtration barrier only after glomerular injury. Therefore, we had an excellent readout to follow podocyte injury in vivo. We generated a custom image analysis software that measures the fluorescence intensity of podocytes and the vasculature automatically on a large scale. Furthermore, we screened a specific drug library consisting of 138 compounds for protective effects on larval podocytes using this in vivo high-content system. The analysis identified several initial hits and the subsequent validation experiments identified belinostat as a reliable and significant protective agent for podocytes. These results led to a patent request and belinostat is a promising candidate for a clinical use and will be tested in mammalian podocyte injury models.